Alan D. Lopez | |
---|---|
Known for | Epidemiology of tobacco |
Awards | John Dirks Canada Gairdner Global Health Award (2018) |
Scientific career | |
Fields | Public health; epidemiology |
Institutions |
Alan Donald Lopez (born 1951) is an Australian global and public health scholar and epidemiologist who focuses on the measurement of population health and the global descriptive epidemiologist of tobacco.
He was a Melbourne Laureate Professor and the Rowden-White Chair of Global Health and Burden of Disease Measurement at The University of Melbourne. [1] He is also the Director of the Global Burden of Disease Group in the Melbourne School of Population and Global Health and a member of the Disease Control Priorities Project. [2] [3]
Prior to working at the University of Melbourne, Lopez worked at the World Health Organization (WHO) in Geneva for 22 years. [2] He held a series of technical and senior managerial posts including Chief epidemiologist in WHO's Tobacco Control Program (1992–95), Manager of WHO's Program on Substance Abuse (1996–98), Director of the Epidemiology and Burden of Disease Unit (1999–2001) and Senior Science Advisor to the Director-General (2002). [2] On leaving the World Health Organization he was appointed as the Head of the School of Population Health at the University of Queensland from 2003-2012. [2]
Lopez is a widely cited author with over 75,000 citations to his work in health and medical research. Most notably, he is the co-founder of the Global Burden of Disease Study with Christopher J.L. Murray, and co-founded the Peto-Lopez method with Sir Richard Peto, to estimate tobacco-attributable mortality from vital statistics. [1] [2] Lopez is on the editorial boards of PLoS Medicine , The International Journal of Epidemiology and Preventive Medicine , BMC Medicine, and is co-Editor in Chief of Population Health Metrics. [4] He is also a member of the Scientific Advisory Committee for the International Network for the Demographic Evaluation of Populations and their Health in Developing Countries (INDEPTH Network). [5] He was a member of the Wellcome Trust Population and Public Health Funding Committee (2007–10), the WHO Expert Committee on Non-communicable Disease Surveillance (2009–11), the United States National Academy of Sciences Panel on Divergent Trends in Longevity (2008–11), the Scientific Board of the Oxford Health Alliance Grand Challenges in Non-Communicable Disease (2006–09), and was former Chair of the Health and Medical Research Council of Queensland. [3]
He has been awarded several major research grants in epidemiology, health services research and population health, including funding from the NHMRC, Wellcome Trust, Bill and Melinda Gates Foundation and AusAID, and is currently the Chief Investigator-A on national and international competitive research grants in excess of A$10 million. [2] He was elected to the Institute of Medicine of the US National Academies of the United States in 2009 and awarded the Peter Wills medal in 2014 by Research Australia for his outstanding contribution in building Australia's international reputation in health and medical research. [2] [6]
In 2016 Lopez was appointed a Companion of the Order of Australia for eminent service to science, both nationally and internationally, as an academic, researcher and author, and to the advancement of planning and policy development to improve public health in developing countries. [7] In 2017 he was elected Fellow of the Australian Academy of Health and Medical Sciences [8] and from 2020-2021 he was a Fellow of the Academy of the Social Sciences in Australia. [9]
In 2021, The Age reported that Lopez was allegedly found to sexually harassed a female colleague, Ashley Frederes, at The University of Melbourne in 2015 at a hotel in Shanghai, China during a meeting with Chinese health officials as part of a university project. An independent investigation found that on the balance of probabilities that Lopez groped Frederes in a lift and making unwanted advances such as attempting kiss her and blocking her from exiting his hotel room. Frederes had been in his hotel room as the meeting rooms were closed at the time and alleged, "He was physically blocking me from leaving and that’s when he went in to hug me, and I just went to hug back to make it quick and leave," in both written and verbal accounts during the investigation. Lopez "categorically denies" the allegations and results of the investigation. He says, "I firmly and absolutely deny ever having touched or intimidated her in the manner which she alleges: none of the actions she described happened then, or on any other occasion." Despite the allegations and investigation into his conduct, Lopez was initially able to keep his position at the university and continued to work there. [10]
Epidemiology is the study and analysis of the distribution, patterns and determinants of health and disease conditions in a defined population.
Sir William Richard Shaboe Doll was a British physician who became an epidemiologist in the mid-20th century and made important contributions to that discipline. He was a pioneer in research linking smoking to health problems. With Ernst Wynder, Bradford Hill and Evarts Graham, he was credited with being the first to prove that smoking increased the risk of lung cancer and heart disease.
David L. Heymann is an American infectious disease epidemiologist and public health expert, based in London.
The Umeå Centre for Global Health Research (UCGHR) was a centre of excellence within Umeå University in northern Sweden. The centre operated within the university's Department of Epidemiology and Global Health, and was led by a steering group chaired by a principal investigator.
The Australian Institute of Tropical Health and Medicine (AITHM) is an Australian tropical health and medical research institute based at James Cook University (JCU) in Townsville and Cairns, Queensland. Formerly known as the Australian Institute of Tropical Medicine, AITHM was established at JCU in 2008.
Anthony John McMichael AO FTSE was an Australian epidemiologist who retired from the Australian National University in 2012.
Prabhat Jha is an Indian-Canadian epidemiologist currently working in the field of global health.
Simon Iain Hay, is a British epidemiologist. He is Professor for Global Health at the University of Washington and Director of Geospatial Science at the Institute for Health Metrics and Evaluation (IHME). From 2013-2015 he served as the 52nd President of the Royal Society of Tropical Medicine and Hygiene.
Dame Anne Mandall Johnson DBE FMedSci is a British epidemiologist, known for her work in public health, especially the areas of HIV, sexually transmitted infections and infectious diseases.
David John Hunter is an Australian epidemiologist and the Richard Doll Professor of Epidemiology and Medicine at Oxford Population Health. He was previously a professor in the Department of Epidemiology and the Department of Nutritionof Harvard University. He was associate epidemiologist at the Channing Laboratory, Brigham and Women's Hospital, where he was involved with the programs in breast cancer, cancer epidemiology, and cancer genetics research teams.
Vikram Harshad Patel FMedSci is an Indian psychiatrist and researcher best known for his work on child development and mental disability in low-resource settings. He is the Co-Founder and former Director of the Centre for Global Mental Health at the London School of Hygiene and Tropical Medicine (LSHTM), Co-Director of the Centre for Control of Chronic Conditions at the Public Health Foundation of India, and the Co-Founder of Sangath, an Indian NGO dedicated to research in the areas of child development, adolescent health and mental health. Since 2024, he has been the Paul Farmer Professor and Chair of the Department of Global Health and Social Medicine at Harvard Medical School in Boston, where he was previously the Pershing Square Professor of Global Health and Social Medicine. He was awarded a Wellcome Trust Principal Research Fellowship in 2015. In April 2015, he was listed as one of the world's 100 most influential people by TIME magazine.
John Danesh is a Professor of Epidemiology and Medicine and the head of the Department of Public Health and Primary Care at the University of Cambridge. He also holds several other leadership roles in scientific organizations, including director of the department's affiliate Strangeways Research Laboratory and founder and director of the Cardiovascular Epidemiology Unit. He is also an associate faculty member at the Wellcome Trust Sanger Institute and an honorary consultant at the Cambridge University Hospitals NHS Foundation Trust. He became a fellow of the Royal College of Physicians in 2007 and of the Academy of Medical Sciences in 2015.
Adele Chandler Green is an Australian epidemiological senior scientist at the QIMR Berghofer Medical Research Institute in Brisbane and is the institute's Head of Cancer and Population Studies Group.
Tolullah "Tolu" Oni is a Nigerian urban epidemiologist at the Medical Research Council Epidemiology Unit at the University of Cambridge. She is a NextEinstein Forum Fellow and World Economic Forum Young Global Leader.
Catherine Kyobutungi is a Ugandan epidemiologist who currently serves as the Executive Director of the African Population and Health Research Center(APHRC) and a Joep Lange Chair at the University of Amsterdam. She was elected to the African Academy of Sciences in 2018.
Elizabeth Lucy Corbett is a British epidemiologist who is Professor of Tropical Epidemiology at the London School of Hygiene & Tropical Medicine. Her research investigates the regulation of tuberculosis in HIV prevalent populations and improving access to HIV self-testing.
Colin Baigent is a British academic physician and cardiovascular epidemiologist. He is a professor of epidemiology, Director of the Medical Research Council Population Health Research Unit at the University of Oxford, and deputy director of the Clinical Trial Service Unit and Epidemiological Studies Unit (CTSU), part of Oxford Population Health. His work is focused in the design and coordination of large-scale randomised trials and the use of meta-analysis to assess the efficacy and safety of drugs for the prevention of cardiovascular disease (CVD) or premature death.
Marc Lipsitch is an American epidemiologist and Professor in the Department of Epidemiology at the Harvard T.H. Chan School of Public Health, where he is the Director of the Center for Communicable Disease Dynamics. He has worked on modeling the transmission of Coronavirus disease 2019 (COVID-19).
Emily Banks is an Australian epidemiologist and public health physician, working mainly on chronic disease. She is a Professor of Epidemiology and Public Health and Head of the Centre for Public Health Data and Policy at the Australian National University, and a visiting professor at the University of Oxford.
Rashida Abbas Ferrand is a British physician and epidemiologist who is a professor at the London School of Hygiene & Tropical Medicine. Her research considers adolescent health and the development of interventions to improve outcomes for people living with HIV. She was awarded the 2018 Chalmers Medal, and elected a Fellow of the Academy of Medical Sciences in 2024.